TABLE IV.
Cost category | Costs |
||
---|---|---|---|
folfox | 5fu/lv | Incremental | |
Within-trial costs | |||
Study chemotherapy | 15,665 | 1,757 | 13,908 |
Outpatient visits | 638 | 661 | −23 |
Lab tests | 236 | 244 | −8 |
Radiologic evaluations | 1,837 | 1,889 | −52 |
Neutropenia | 2,553 | 226 | 2,328 |
Neuropathy | 0 | 0 | 0 |
Diarrhea | 13 | 11 | 2 |
Nausea and vomiting | 10 | 3 | 6 |
Serious adverse events | 1,677 | 1,041 | 636 |
Relapse treatment | 3,074 | 4,175 | −1,100 |
Relapse follow-up | 429 | 618 | −189 |
TOTAL | 26,133 | 10,623 | 15,509 |
Beyond-trial costs | |||
Relapse | 200 | 297 | −97 |
Follow-up | 1,106 | 998 | 108 |
Other | 287 | 398 | −111 |
LIFETIME TOTAL | 27,726 | 12,317 | 15,409 |
folfox = folinic acid, 5-fluorouracil, oxaliplatin; 5fu = 5-fluorouracil; lv = leucovorin.